Reviewing the Understanding of the Treatment Guidelines for Schizophrenia & Major Depressive Disorder

Research Paper Title

Improvements in the degree of understanding of the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study.

Background

To implement clinical practice guidelines (CPGs), it is necessary for psychiatrists to deepen their understanding of the CPGs. The Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project is a nationwide dissemination and implementation study of two sets of CPGs for schizophrenia and major depressive disorder (MDD).

Methods

A total of 413 psychiatrists (n = 212 in 2016; n = 201 in 2017) learned the two CPGs in the education program of the EGUIDE project, and clinical knowledge of these CPGs was evaluated at baseline and after the programs. To improve the correct answer rate for clinical knowledge after the programs, we revised the lecture materials associated with items that had a low correct answer rate in 2016 and used the revised lecture materials with the CPGs in 2017. The rates of correct answers after the programmes between the 2016 and 2017 groups were compared.

Results

The correct answer rate of one item on the schizophrenia CPG and one item on the MDD CPG tended to be improved (S-D5 and D-C6) and that of one on the MDD CPG was significantly improved (D-D3, P = 0.0008) in the 2017 group compared to those in the 2016 group.

Conclusions

The researchers reported improvements in clinical knowledge of CPGs after the EGUIDE program in the 2017 group following revision of the lecture materials based on results from the 2016 group. These attempts to improve the degree of understanding of CPGs may facilitate the successful dissemination and implementation of psychiatric guidelines in everyday practice.

Reference

Numata, S., Nakataki, M., Hasegawa, N., Takaesu, Y., Takeshima, M., Onitsuka, T., Nakamura, T., Edagawa, R., do, H., Miura, K., Matsumoto, J., Yasui-Fiurukori, N., Kishimoto, T., Hori, H., Tsuboi, T., Yasuda, Y., Furihata, R., Muraoka, H., Ochi, S., Nagasawa, T., Kyou, Y., Murata, A., Katsumoto, E., Ohi, K., Hishimoto, A., Inada, K., Watanabe, K. & Hashimoto, R. (2021) Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study. Neuropsychopharmacology Reports. doi: 10.1002/npr2.12173. Online ahead of print.

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.